Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model

Shock

Volumn 34, Issue 5, 2010, Pages 495-501

  Xie, Keliang ^a   Yu, Yonghao ^a   Zhang, Zishen ^b   Liu, Wenbo ^b   Pei, Yuping ^b   Xiong, Lize ^b   Hou, Lichao ^b   Wang, Guolin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

antioxidant enzyme; hydrogen gas; inflammatory cytokines; multiple organ dysfunction syndrome failure; reactive oxygen species; Sepsis

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; HIGH MOBILITY GROUP B1 PROTEIN; HYDROGEN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CECUM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; KIDNEY; LIGATION; LIVER; LUNG; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; SEPSIS; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, INHALATION; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CYTOKINES; DINOPROST; DRUG EVALUATION, PRECLINICAL; GASES; HMGB1 PROTEIN; HYDROGEN; INFLAMMATION; MALE; MICE; MICE, INBRED ICR; MULTIPLE ORGAN FAILURE; OXIDATION-REDUCTION; SUPEROXIDE DISMUTASE; VISCERA; ZYMOSAN;

EID: 78149282656     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181def9aa     Document Type: Article

References (25)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
2. Shayevitz JR, Miller C, Johnson KJ, Rodriguez JL: Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock 4:389-396, 1995.
3. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
4. Biswal S, Remick DG: Sepsis: redox mechanisms and therapeutic opportunities. Antioxid Redox Signal 9:1959-1961, 2007.
5. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S, Takahashi R, Fukui M, Hasegawa G, Nakamura N, et al.: Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun 375:346-350, 2008.
6. Ohta S: Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept. Nippon Ronen Igakkai Zasshi 45:355-362, 2008.
7. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, et al.: Hydrogen therapy reduces apoptosis in neonatal hypoxiaischemia rat model. Neurosci Lett 441:167-172, 2008.
8. Mao YF, Zheng XF, Cai JM, You XM, Deng XM, Zhang JH, Jiang L, Sun XJ: Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun 381:602-605, 2009.
9. Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S, et al.: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 373:30-35, 2008.
10. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S: Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun 361:670-674, 2007.
11. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S: Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13:688-694, 2007.
12. Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L, Wang G: Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock 34:90-97, 2010.
13. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP: Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat. Crit Care Med 27:1524-1532, 1999.
14. Hou L, Xie K, Li N, Qin M, Lu Y, Ma S, Ji G, Xiong L: 100% Oxygen inhalation protects against zymosan-induced sterile sepsis in mice: the roles of inflammatory cytokines and antioxidant enzymes. Shock 32:451-461, 2009.
15. Volman TJ, Hendriks T, Goris RJ: Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23:291-297, 2005.
16. Hou L, Xie K, Qin M, Peng D, Ma S, Shang L, Li N, Li S, Ji G, Lu Y, et al.: Effects of reactive oxygen species (ROS) scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice. Shock 33:646-654, 2009.
17. Dworski R, Roberts LJ 2nd, Murray JJ, Morrow JD, Hartert TV, Sheller JR: Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy 31:387-390, 2001.
18. Liu DD, Kao SJ, Chen HI: N-acetylcysteine attenuates acute lung injury induced by fat embolism. Crit Care Med 36:565-571, 2008.
19. Sauer H, Wartenberg M, Hescheler J: Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11:173-186, 2001.
20. Winterbourn CC: Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181:223-227, 2002.
21. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
22. Hou LC, Qin MZ, Zheng LN, Lu Y, Wang Q, Peng DR, Yu XP, Xin YC, Ji GL, Xiong LZ: Severity of sepsis correlated with the elevation of serum high-mobility group box 1 in rats. Chin Med J 122:449-454, 2009.
23. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al.: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570, 2000.
24. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, Di Raimo R, et al.: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101:296-301, 2004.
25. Deitch EA, Kemper AC, Specian RD, Berg RD: A study of the relationship among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J Trauma 32:141-147, 1992.